The lipoxygenase pathway in the human NK cell system.
D000818:Animals; D001091:Arachidonate Lipoxygenases; D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000378:metabolism; D003994:Bucladesine / Q000494:pharmacology; D002143:Callitrichinae; D002396:Catechols / Q000494:pharmacology; D002460:Cell Line; D002472:Cell Transformation, Viral; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D003995:Dibutyryl Cyclic GMP / Q000494:pharmacology; D006564:Herpesviridae; D006801:Humans; D066298:In Vitro Techniques; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D007975:Leukotriene B4 / Q000378:metabolism; D008084:Lipoxygenase / Q000378:metabolism*; D016859:Lipoxygenase Inhibitors; D009637:Masoprocol
D001095:Arachidonic Acids; D002396:Catechols; D016859:Lipoxygenase Inhibitors; D007975:Leukotriene B4; D016718:Arachidonic Acid; D003995:Dibutyryl Cyclic GMP; D003994:Bucladesine; D009637:Masoprocol; D001091:Arachidonate Lipoxygenases; D008084:Lipoxygenase